224 related articles for article (PubMed ID: 16117711)
1. Tuberculosis: from genome to vaccine.
de Jonge MI; Brosch R; Brodin P; Demangel C; Cole ST
Expert Rev Vaccines; 2005 Aug; 4(4):541-51. PubMed ID: 16117711
[TBL] [Abstract][Full Text] [Related]
2. The use of mutant mycobacteria as new vaccines to prevent tuberculosis.
Hernàndez Pando R; Aguilar LD; Infante E; Cataldi A; Bigi F; Martin C; Gicquel B
Tuberculosis (Edinb); 2006; 86(3-4):203-10. PubMed ID: 16542875
[TBL] [Abstract][Full Text] [Related]
3. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis vaccines: past, present and future.
Martin C
Curr Opin Pulm Med; 2006 May; 12(3):186-91. PubMed ID: 16582673
[TBL] [Abstract][Full Text] [Related]
5. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
6. Current tuberculosis vaccine development.
Young DB
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S254-6. PubMed ID: 10875794
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in improved tuberculosis vaccines.
McMurray DN
Indian J Pediatr; 2000 Feb; 67(2 Suppl):S58-62. PubMed ID: 11129910
[TBL] [Abstract][Full Text] [Related]
8. New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development.
Kamath AT; Fruth U; Brennan MJ; Dobbelaer R; Hubrechts P; Ho MM; Mayner RE; Thole J; Walker KB; Liu M; Lambert PH; ;
Vaccine; 2005 May; 23(29):3753-61. PubMed ID: 15893612
[TBL] [Abstract][Full Text] [Related]
9. [Perspectives for new anti-tuberculous vaccines in the post-genomic era].
García LF; Barrera LF
Biomedica; 2004 Jun; 24 Supp 1():228-38. PubMed ID: 15495589
[TBL] [Abstract][Full Text] [Related]
10. Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis.
Kaufmann SH; Baumann S; Nasser Eddine A
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1068-79. PubMed ID: 17044198
[TBL] [Abstract][Full Text] [Related]
11. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
[TBL] [Abstract][Full Text] [Related]
12. A review of vaccine research and development: tuberculosis.
Girard MP; Fruth U; Kieny MP
Vaccine; 2005 Dec; 23(50):5725-31. PubMed ID: 16153751
[TBL] [Abstract][Full Text] [Related]
13. [Strategies for the development of new tuberculosis vaccines].
Fattorini L
Minerva Med; 2007 Apr; 98(2):109-19. PubMed ID: 17519853
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.
Sable SB; Kalra M; Verma I; Khuller GK
Clin Immunol; 2007 Mar; 122(3):239-51. PubMed ID: 17208519
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis: vaccines in the pipeline.
Ly LH; McMurray DN
Expert Rev Vaccines; 2008 Jul; 7(5):635-50. PubMed ID: 18564018
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge.
Vipond J; Vipond R; Allen-Vercoe E; Clark SO; Hatch GJ; Gooch KE; Bacon J; Hampshire T; Shuttleworth H; Minton NP; Blake K; Williams A; Marsh PD
Vaccine; 2006 Sep; 24(37-39):6340-50. PubMed ID: 16781800
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
[TBL] [Abstract][Full Text] [Related]
19. Recombinant and synthetic peptides to identify Mycobacterium tuberculosis antigens and epitopes of diagnostic and vaccine relevance.
Mustafa AS
Tuberculosis (Edinb); 2005; 85(5-6):367-76. PubMed ID: 16253561
[TBL] [Abstract][Full Text] [Related]
20. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.
Xing Z; Charters TJ
Expert Rev Vaccines; 2007 Aug; 6(4):539-46. PubMed ID: 17669008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
